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Dyspepsia is a pain or discomfort in the upper abdomen 
or chest. It is often described as a feeling of having gas, of 
fullness, or a gnawing or burning pain. Dyspepsia patients 
with no peptic ulceration are collectively labelled as having 
non-ulcer dyspepsia (NUD).  It is a common gastrointestinal 
symptom experienced by 20 - 40% of the adult population in 
the Western world.1  Often a person with dyspepsia is treated 
without having laboratory tests done. However, when tests are 
done, in about 50% of cases no abnormalities are identified.1
   Patients with NUD are usually healthy, eat regularly and live 
with their symptoms for months or years without suffering 
from adverse health problems.2
   Treating NUD can be difficult for sufferers as they face an 
array of over-the-counter (OTC) and prescription remedies. 
The objectives of OTC treatment are to reduce acidity by 
raising the pH level, to enhance mucosal protection, and to 
expel excess gas.1  Antacids are the best medication for fast 
and effective relief from NUD because of their rapid acid-
neutralising properties.1
   All antacids are basic compounds that react with 
gastric acid to form water and a salt. There are 4 primary 
neutralising compounds found in OTC antacid products: 
sodium bicarbonate, calcium carbonate, aluminum salts 
and magnesium salts. All antacids contain at least one of 
these ingredients, which differ significantly in potency, 
gastrointestinal side-effects, systemic complications, and drug 
interactions. Most of these properties are determined by the 
metal cation of the antacid and the degree of its systemic 
absorption.3  It is documented that the buffering capacity of 
magnesium salts is greater than that of aluminum hydroxide 
but less than that of sodium bicarbonate and calcium 
carbonate.3
   Non-drug home remedies such as commercially available 
milk are frequently used to relieve dyspepsia.  Other remedies 
include goat’s milk and soy milk.
   The concentrations of phosphates, calcium and caseins 
in milk have a major effect on its buffering capacity.4  The 
buffering capacity is the ability of a solution to withstand a 
drop in pH, even following an input of lactic acid, resulting 
from activity of lactic acid bacteria.  Therefore, in a weakly 
buffered milk, the pH will drop rapidly, e.g. from 6.6 to 
6.0, following the addition of a little lactic acid.  In strongly 
buffered milk the pH will decline only slightly, e.g. from 6.6 
to 6.4, even if a lot of lactic acid is added. The good buffering 
capacity of milk is therefore ideal in the treatment of NUD.  
The principal buffering components of goat’s milk are proteins 
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Background. Non-ulcer dyspepsia (NUD) is the term most 
commonly used to describe a heterogeneous and often ill-
defined group of dyspepsia patients whose symptoms of upper 
abdominal pain, discomfort or nausea persist in the absence of 
identifiable cause. Treatment choice commonly includes over-
the-counter medicines and home remedies, e.g. milk. 
Objective. To determine the relative buffering capacity of 
goat’s, cow’s and soy milk, non-prescription antacid drugs and 
combinations thereof. 
Methods. The buffering capacities of 25 ml aliquots of each 
of the powdered milk products, the antacids alone and the 
combination of antacid and milk were determined. Statistical 
analysis was used to determine any significant differences in 
buffering capacity. 
Results. When the antacids were examined alone, significant 
differences in buffering capacity were observed. When 
powdered milk products were examined alone, cow’s milk had 
a significantly higher buffering capacity than either goat’s or 
soy milk. There was no significant difference between goat’s 
and soy milk. In the combination of cow’s milk with each of 
the antacids, brand A and B had a similar buffering capacity, 
significantly higher than that observed with brand C. 
Conclusions. The combination with best observed buffering 
capacity was brand A with cow’s milk, and the weakest 
buffering capacity was observed with brand C with soy 
milk. The results obtained can be attributed to the chemical 
constituents of the antacids and the milk products. 
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and phosphates, while the major buffering components of 
cow’s milk are the casein protein, calcium and the phosphates.  
Goat’s milk is slightly on the acid side, with a pH range of 6.4 
- 6.7.5  Soy milk is an excellent substitute for cow’s milk and 
is far more digestible and compatible with human nutritional 
requirements than cow’s milk. Soy milk reduces many 
digestive disorders because of its high fibre content. This aids 
in healthy digestion, and it has been shown to reduce the risk 
of colon and rectal cancer. Soy milk is also dairy-free and can 
be used as a substitute in cases of lactose intolerance and milk 
allergy.6 
Objectives
Powdered cow’s, soy and goat’s milk have not been assessed 
adequately or compared with regard to their buffering 
capacity, so the aim of the study was to determine the relative 
buffering capacity of these powdered milks and commercial 
non-prescription antacid drugs. The primary objectives were to 
determine the buffering capacity of each product, and by using 
appropriate statistics, to determine whether the milk products 
and antacid preparations differed from each other with regard 
to buffering capacity individually and in combination.  The 
secondary objectives were to identify synergistic buffering 
mechanisms, and to determine the most cost-effective 
treatment with regard to buffering capacity.
Materials
Milk
Commercially available powdered cow’s, goat’s and soy milks 
were selected for this study.  The primary selection criteria 
for these products were based on availability and cost.  The 
powdered milk formulas of all three products were more 
available commercially than the natural (liquid) preparations, 
as evidenced by the availability of the products in major retail 
stores. Various brands were available for each individual milk 
product, and in each case the most affordable was selected 
for the study.  The approximate costs of the milk products are 
reflected in Table I.
Non-prescription antacid drugs
Three different brands were selected for the study (Table II). 
The selection criteria were again based on availability and cost.  
However, brand popularity was also considered by enquiring 
at local retail and hospital pharmacies. This was done to 
establish which brands were popular among consumers, and 
based on this the most affordable brands were selected. 
Other chemicals
Hydrochloric acid 0.5M (BDH Laboratory Supplies, Poole, UK) 
was used as supplied. HCl 0.1M was not selected because it 
produced insufficient responses as a titrant.
Equipment
The Hanna pH 211 Microprocessor pH meter (Hanna 
Instruments Inc., Lisbon, Portugal) was used for all 
experiments.  Temperature was maintained at 22 - 23°C.
Methods
As stated, buffering capacities were determined for the 
individual products and for the combinations (Fig. 1).
   To maintain standardisation, calculated quantities of 
powdered milk, in accordance with label specifications, were 
solubilised in 200 ml distilled water to produce individual 
standardised solutions.  Each antacid tablet was triturated and 
adequately solubilised in 200 ml distilled water.  Thereafter 
each individual antacid tablet was triturated and solubilised in 
200 ml powdered milk solution. Twenty-five millilitre aliquots 
of each of these solutions were used as representative samples 
in the in vitro testing.  This incorporated measurement of the 
initial pH of the solutions without treatment with hydrochloric 
Fig. 1. Flow diagram depicting the method used to determine 
buffering capacity.Table I. Cost of powdered milk products 
Milk Cost  (R/200 ml)
Goat 3.30 
Soy 1.44 
Cow  1.20
Table II. Constituents of the antacid preparations
     Quantity  Cost   
Brand Constituent       (mg) (R/tablet)
A Calcium carbonate 680 0.41
 Magnesium carbonate   80 
B Alginic acid 500 1.80
 Magnesium trisilicate   25 
 Aluminium hydroxide gel 100 
 Sodium bicarbonate 170 
C Aluminium hydroxide gel 250 1.04
 Magnesium trisilicate 500
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acid.  One-millilitre increments of 0.5M hydrochloric acid were 
then added to the standardised solutions of the milk, antacid or 
the combination solution, reaching a maximum volume of 5 ml. 
It was found that any further addition of acid did not result 
in a fluctuation in pH, i.e. the pH remained constant.  In this 
step the final pH was measured after the treatment with the 
0.5M hydrochloric acid.  A minimum of 3 runs per tablet were 
performed to obtain an average measure of pH change.  Using 
van Slyke’s8 proposed mathematical equation, the buffering 
capacities of each individual product and combination were 
determined as follows:
dBC =                (volume of acid added) × (molarity of acid)
dpH   (volume of milk/antacid/combination solution) × (pH change)
Statistical analysis
The data generated were analysed by applying the appropriate 
statistical package to establish whether there was significance 
within products and within combinations.  The techniques 
employed were analysis of variance (ANOVA) and the general 
linear model which incorporated Duncan’s multiple range test. 
The level of significance was set at p < 0.05. 
Results and discussion
Comparative analysis of buffering capacities revealed the 
following:
Drug alone
Fig. 2 shows that brand A provided a significantly higher 
buffering capacity than brands B or C (p < 0.05).
It has been stated that calcium carbonate and sodium 
bicarbonate have the best buffering capacity followed by 
magnesium salt and then aluminium hydroxide.3  Therefore 
the difference in buffering capacity can be attributed to the 
different constituents in each formulation.
   Although brands A and B contained equally superior 
buffering capacity constituents, i.e. calcium carbonate and 
sodium bicarbonate respectively, brand A’s superior buffering 
capacity could be attributed primarily to its higher quantity of 
calcium carbonate (680 mg) compared with 170 mg of sodium 
bicarbonate in brand B.
   Calcium carbonate dissolves more slowly in the stomach 
than sodium bicarbonate, but it produces a potent and 
prolonged neutralisation of gastric acid. It reacts with gastric 
acid to produce calcium chloride, carbon dioxide and water. 
The chemical reaction is as follows:
CaCO2 + 2HCl        CaCl2 + H2O + CO2
   Sodium bicarbonate is a potent, highly soluble compound 
that reacts almost instantaneously with acid in the stomach 
to produce sodium chloride, carbon dioxide and water. The 
chemical reaction is as follows:
NaHCO3 + HCl        NaCl + H2O + CO2
   The loss of carbon dioxide as a gas makes the reaction 
irreversible. 
   Although brand B was a multi-ingredient product, it proved 
to have a lower buffering capacity than brand A.  Its buffering 
capacity was mainly provided by the sodium bicarbonate and 
the aluminium hydroxide.  Alginic acid, on the other hand, 
reacts with the sodium bicarbonate and aluminium hydroxide 
to provide a cytoprotective role. In addition the magnesium 
trisilicate is metabolised to the magnesium carbonate buffer 
and the trisilicic acid which also has a cytoprotective role.
   Another reason for its weaker buffering capacity is as stated 
above in terms of quantity of buffering capacity constituents.
   Aluminium hydroxide is slowly dissolved in the stomach, 
where it reacts with gastric acid to form aluminium chloride 
and water. The chemical reaction is as follows: 
Al (OH)3 + 3 HCl         AlCl3 + 3 H2O
   Alginic acid works by reacting with sodium bicarbonate 
and saliva to form a viscous solution of sodium alginate. This 
viscous solution floats on the surface of the gastric contents so 
that when reflux occurs, sodium alginate rather than acid is 
refluxed and irritation is minimised.
   Use of alginic acid-containing products is not indicated for 
acid-peptic diseases other than gastro-oesophageal disease 
because the amount of antacid ingredients included does not 
provide sufficient acid-neutralising capacity to be useful.
   Brand B had a significantly higher buffering capacity 
than brand C (p < 0.05). Although both products contained 
magnesium trisilicate and aluminium hydroxide, the reason 
for the higher buffering capacity of brand B was the sodium 
bicarbonate content.
   Magnesium trisilicate is decomposed by hydrochloric acid 
into a magnesium salt and trisilicic acid: 
2 MgO. 3SiO3 + 4 HCl         MgCl2 + H4Si3O8
                                          Trisilicic acid
In the stomach, the gelatinous trisilicic acid is formed with 
gastric hydrochloric acid.3
Milk alone
Fig. 3 shows that powdered cow’s milk provided a better 
buffering capacity than either powdered goat’s or soy milk  
(p < 0.05).
Fig. 2. Buffering capacity of individual drugs.
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   The composition of milk has a direct influence on the 
buffering capacity.  The concentrations of proteins, phosphates 
and calcium in milk generally provide potent buffering 
mechanisms.5
   Proteins contain amino acids that undergo the following 
equilibria: 
NH2 + H
+                  NH3
COOH + OH-               COO- + H2O
Addition of acid drives both equilibria in the direction that 
absorbs the added H+, thereby minimising the decrease in pH. 
Similarly, addition of a buffer removes H+ from the solution, 
driving both equilibria in the direction that increases H+, again 
minimising the increase in pH.9
   Phosphates undergo the following equilibria: 
PO4
-3
(aq)  + H
+ (aq)                 HPO4
-2(aq)
HPO4
-2
(aq)   + H
+ (aq)               H2PO4-(aq)
H2PO4-(aq)   + H
+ (aq)                H4PO4(aq).
   Addition of acid will drive the equilibria to the right, 
removing much of the added acid and maintaining a constant 
pH.  Addition of base will drive all equilibria to the left (by 
removing H† ions in the equilibrium H+  +  OH-                H2O) 
and in the same way counteract the effect of the addition of the 
base.  In both cases, the overall effect is to minimise the change 
in pH.9
   Calcium. At the normal pH of milk more than 90% of the 
calcium is bound in colloidal form to the casein micelles and 
less than 10% exists in ionised form.  As the pH is lowered, 
the colloidal calcium is displaced from the micelles as the 
binding sites become protonated.  In milk, calcium is bound to 
phosphates, which in turn are bound to the protein micelles.  
On addition of acid, phosphate ions are displaced from the 
calcium.  Further addition of acid increases the solubility of the 
phosphate ions.7
   According to package specifications the cow’s milk contained 
not only all three buffering constituents, but all three in a 
greater quantity than in goat’s milk or soy milk powder.
   In addition, cow’s milk contains the protein, casein, which 
provides the most potent buffering capacity when used in 
combination with phosphates.  On the other hand, goat’s milk 
and soy milk powder contain no or very little casein.
   Hence in strongly buffered milk the pH will decline only 
slightly, and in weakly buffered milk the pH will drop rapidly.5 
   When cow’s milk and antacids were examined together, 
brands A and B had similar buffering capacities, significantly 
higher than that of brand C (p < 0.05) (Fig. 4). This was 
attributed to the casein, phosphates and calcium in cow’s milk 
and the greater quantities of calcium carbonate in brand A.
   When goat’s milk and antacids were examined together 
brand B had the greatest buffering capacity, greater than those 
of both brands A and C.
   When soy milk and antacids were examined together brand 
A had a slightly higher buffering capacity than those of either 
brands B or C in soy milk.
   Brand A once again provided greater buffering owing to the 
greater quantity of calcium carbonate in the formulation.
   Table III shows the mean buffering capacity and standard 
deviation of the samples tested in this study.
Conclusion
In conclusion, brand A alone and cow’s milk alone provided 
equally superior buffering capacity compared with the other 
products, and as a combination they provided the most 
potent buffering capacity, although not significantly greater 
(p > 0.05) than when used alone.  Therefore, when using cost-
effectiveness as a factor, cow’s milk powder alone (R1.20/ 
200 ml), or brand A alone (R 0.41/tablet), would have to be 
recommended as treatment options in NUD.
Recommendations
The study focused on three commonly used antacids, and 
future studies should therefore include analysis of a wider 
spectrum of OTC antacids with varied buffering constituents.
Fig. 3. Buffering capacity of powdered milks.
Fig. 4. Buffering capacities of combinations.
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It has been documented that buffering capacities of formulas 
were lower than those of natural products;7 since powdered 
milk was used in this study, analysis of natural (liquid) 
preparations of each of the milk products is therefore 
recommended.  Development of a product containing the 
principal buffering components of both cow’s milk and brand 
A would be beneficial in the treatment of NUD.  Future studies 
should also include a comparative analysis of acid-neutralising 
capacity and buffering capacity.
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Table III. Mean buffering capacity and the standard 
deviation of the samples tested
  Standard   
 Mean deviation
Brand A alone 0.3245 0.0079
Brand B alone 0.0215 0.0014
Brand C alone 0.0112 0.0002
Cow’s milk 0.3196 0.0154
Goat’s milk 0.0221 0.0004
Soy milk 0.0192 0.0001
Brand A + cow’s milk 0.3515 0.0162
Brand A + goat’s milk 0.0423 0.0137
Brand A + soy milk 0.0250 0.0004
Brand B + cow’s milk 0.3346 0.0154
Brand B + goat’s milk 0.3105 0.0537
Brand B + soy milk 0.0246 0.0002
Brand C + cow’s milk 0.2656 0.0281
Brand C + goat’s milk 0.1301 0.0433
Brand C + soy milk 0.0225 0.0001
List price: R2205.00
Member price: R1875.00
Pg 57-61.indd   61 12/15/05   12:13:08 PM
